Suppr超能文献

洋地黄疗法在充血性心力衰竭患者中的当前作用。

Current role of digitalis therapy in patients with congestive heart failure.

作者信息

Kulick D L, Rahimtoola S H

机构信息

Department of Medicine, University of Southern California School of Medicine, Los Angeles 90033.

出版信息

JAMA. 1991 Jun 12;265(22):2995-7.

PMID:2033773
Abstract

Digitalis has been used in the treatment of chronic congestive heart failure for 215 years. In this article, numerous clinical studies and trials that have evaluated the efficacy of digitalis in the treatment of patients with congestive heart failure are reviewed. The data indicate that digitalis is a valuable therapeutic agent for relieving symptoms and improving exercise performance and left ventricular function in patients with congestive heart failure. Comparison of the various advantages and disadvantages of digitalis with alternative therapies in patients with congestive heart failure shows an important continuing role for digitalis therapy.

摘要

洋地黄已用于治疗慢性充血性心力衰竭达215年之久。本文回顾了众多评估洋地黄治疗充血性心力衰竭患者疗效的临床研究和试验。数据表明,洋地黄是缓解充血性心力衰竭患者症状、改善运动能力和左心室功能的一种有价值的治疗药物。比较洋地黄与充血性心力衰竭患者其他替代疗法的各种优缺点可知,洋地黄疗法仍具有重要作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验